- Home
- TEVA vs PHM Comparison
TEVA vs PHM Comparison
Compare TEVA & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- PHM
- Stock Information
- Founded
- TEVA 1901
- PHM 1950
- Country
- TEVA Israel
- PHM United States
- Employees
- TEVA N/A
- PHM N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- PHM Homebuilding
- Sector
- TEVA Health Care
- PHM Consumer Discretionary
- Exchange
- TEVA Nasdaq
- PHM Nasdaq
- Market Cap
- TEVA 20.1B
- PHM 21.0B
- IPO Year
- TEVA N/A
- PHM N/A
- Fundamental
- Price
- TEVA $16.72
- PHM $105.13
- Analyst Decision
- TEVA Strong Buy
- PHM Buy
- Analyst Count
- TEVA 8
- PHM 15
- Target Price
- TEVA $24.50
- PHM $132.21
- AVG Volume (30 Days)
- TEVA 10.5M
- PHM 1.8M
- Earning Date
- TEVA 07-30-2025
- PHM 07-22-2025
- Dividend Yield
- TEVA N/A
- PHM 0.83%
- EPS Growth
- TEVA N/A
- PHM 13.61
- EPS
- TEVA N/A
- PHM 14.20
- Revenue
- TEVA $16,616,000,000.00
- PHM $17,890,440,000.00
- Revenue This Year
- TEVA $5.69
- PHM N/A
- Revenue Next Year
- TEVA N/A
- PHM $2.46
- P/E Ratio
- TEVA N/A
- PHM $7.44
- Revenue Growth
- TEVA 3.82
- PHM 8.86
- 52 Week Low
- TEVA $12.47
- PHM $88.07
- 52 Week High
- TEVA $22.80
- PHM $149.47
- Technical
- Relative Strength Index (RSI)
- TEVA 44.93
- PHM 57.67
- Support Level
- TEVA $16.65
- PHM $102.17
- Resistance Level
- TEVA $17.31
- PHM $106.42
- Average True Range (ATR)
- TEVA 0.49
- PHM 3.06
- MACD
- TEVA -0.13
- PHM 0.42
- Stochastic Oscillator
- TEVA 0.00
- PHM 75.18
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.